Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP487629.RAoZeZEhU58-3z-Nj4Xzygcz_MWmO6wLT43UwsuKsz5Zs130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487629.RAoZeZEhU58-3z-Nj4Xzygcz_MWmO6wLT43UwsuKsz5Zs130_provenance.
• NP264129.RAJ91yICpQwW5oDdtye1j6KCRfDEl4Zdu0bjS7vVWhBw4130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264129.RAJ91yICpQwW5oDdtye1j6KCRfDEl4Zdu0bjS7vVWhBw4130_provenance.
• NP476414.RATabn6rV4XWyGFgD346YoBadd9YalxtDFRsIvrrrY-rc130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476414.RATabn6rV4XWyGFgD346YoBadd9YalxtDFRsIvrrrY-rc130_provenance.
• NP313702.RAaPh0H2n4OW0CcBRvXBN_AIafjUJRjH-aQtUz-E5IpDE130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313702.RAaPh0H2n4OW0CcBRvXBN_AIafjUJRjH-aQtUz-E5IpDE130_provenance.
• NP313705.RAWuqvwwprlafq9YlH_i0uG_NqaJJsbDpdLFiQOPOjJ8U130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313705.RAWuqvwwprlafq9YlH_i0uG_NqaJJsbDpdLFiQOPOjJ8U130_provenance.
• NP477600.RAmRhjMFruPe2ZKfJu9Ds__RHPLS9GvurUYbxkhVCgBWo130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477600.RAmRhjMFruPe2ZKfJu9Ds__RHPLS9GvurUYbxkhVCgBWo130_provenance.
• NP476408.RAEorOY58W32eyjzHqbZBf9Wped_dRaXmRFLC8oyvFZLo130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476408.RAEorOY58W32eyjzHqbZBf9Wped_dRaXmRFLC8oyvFZLo130_provenance.
• NP477606.RALqfn3uNa3S78vkGA8lb72J0eVIVeD4CE5yKsSfOZVHE130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477606.RALqfn3uNa3S78vkGA8lb72J0eVIVeD4CE5yKsSfOZVHE130_provenance.
• NP313703.RA_imuK0eaoBXRg2LZLpFlxOXufiW5TC4KyKbMSUTphrM130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313703.RA_imuK0eaoBXRg2LZLpFlxOXufiW5TC4KyKbMSUTphrM130_provenance.
• NP313704.RA57Jazf6e2WIjKaJuw-sNUL8WsZTPtW_P-SnAEST_bjo130_assertion description "[Liver transplant recipients with recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-alpha (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313704.RA57Jazf6e2WIjKaJuw-sNUL8WsZTPtW_P-SnAEST_bjo130_provenance.